Glenmark Pharmaceuticals Limited has informed the Exchange regarding a press release dated April 01, 2025, titled "Glenmark Pharmaceuticals Inc., USA launches Vancomycin Hydrochloride for Injection USP, 750mg/vial, 1.25 g/vial and 1.5 g/vial (Single-Dose Vial)".